AKBA
Akebia Therapeut (AKBA)
NASDAQ
$1.11+$0.01 (+0.91%)
Price as of Jun 23, 2026 7:57 PM EDT
  • $292.4M
    Market Cap
  • -70.05%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 65
Valuation
AKBA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 32
Valuation
AKBA
vs History
vs S&P 500
3-Month Momentum
-28.17%
12-Month Momentum
-71.98%
3-Month Risk Adjusted Momentum
-79.07%
12-Month Risk Adjusted Momentum
-98.81%

True Yield

N/A
Valuation
AKBA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
1.88%

Financial Health Score

Score: 97
Valuation
AKBA
vs History
vs S&P 500
Ohlson's O-Score
7